Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients
- PMID: 1648329
Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients
Abstract
Between September 1983 and January 1990, 64 patients with Klatskin tumors were treated with resective therapy in the Academic Medical Centre Amsterdam. Twenty-nine patients received postoperative adjuvant radiotherapy, 22 patients were treated with resective therapy only and there were 13 postoperative deaths. The longterm results in the patients treated with or without adjuvant radiotherapy were retrospectively assessed. Three patients had a curative resection. Comparison of both therapeutic modalities demonstrated a statistically significant difference in survival (P less than 0.001) in favour of the patients who were treated with additive radiotherapy. The radiotherapy was generally well tolerated.
Similar articles
-
The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.Hepatogastroenterology. 2001 Sep-Oct;48(41):1298-301. Hepatogastroenterology. 2001. PMID: 11677950
-
External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):772-9. doi: 10.1016/j.ijrobp.2006.05.061. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011452
-
Diagnostic and surgical features of Klatskin tumors.Chir Ital. 1999 Jan-Feb;51(1):1-7. Chir Ital. 1999. PMID: 10514910
-
Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.World J Surg. 2003 Feb;27(2):173-9. doi: 10.1007/s00268-002-6434-1. World J Surg. 2003. PMID: 12616432
-
What constitutes long-term survival after surgery for hilar cholangiocarcinoma?Cancer. 1997 Jan 1;79(1):26-34. Cancer. 1997. PMID: 8988723 Review.
Cited by
-
Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?J Gastrointest Cancer. 2022 Dec;53(4):1104-1112. doi: 10.1007/s12029-021-00735-6. Epub 2021 Nov 5. J Gastrointest Cancer. 2022. PMID: 34738188 Review.
-
Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.J Gastrointest Surg. 1998 May-Jun;2(3):283-91. doi: 10.1016/s1091-255x(98)80024-3. J Gastrointest Surg. 1998. PMID: 9841986
-
Interleukin-2 gene-encoded stromal cells inhibit the growth of metastatic cholangiocarcinomas.World J Gastroenterol. 2006 Mar 28;12(12):1889-94. doi: 10.3748/wjg.v12.i12.1889. World J Gastroenterol. 2006. PMID: 16609995 Free PMC article.
-
Trans-hepatic technique and intraluminal Pulsed Dose Rate (PDR-BT) brachytherapy in treatment of locally advanced bile duct and pancreas cancer.J Contemp Brachytherapy. 2009 Jun;1(2):97-104. Epub 2009 Jul 17. J Contemp Brachytherapy. 2009. PMID: 27795719 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical